Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 311 of 1,261

  1. US 11129823

    Combination treatment of ocular inflammatory disorders and diseases

    Aldeyra Therapeutics, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  2. US 11129794

    Chemically modified small molecules

    Nektar Therapeutics · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  3. US 11130795

    CD154 peptides and methods of inhibiting CD40 interactions with CD154

    The Regents of the University of Colorado · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  4. US 11129835

    Methods and compositions for the inhibition of PIN1

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  5. US 11129881

    Peptide conjugated particles

    Northwestern University · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  6. US 11130956

    Reducing the toxicity of agrobacterium endotoxin

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  7. US 11130953

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  8. US 11130785

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  9. US 11130778

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  10. US 11130772

    CYP-eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  11. US 11130759

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  12. US 11130777

    Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1-beta-L-ribofuranosyl)-1H-benzimidazole

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  13. US 11129940

    Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes

    XERIS PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  14. US 11129908

    Gene therapy vectors for treating heart disease

    Tenaya Therapeutics, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  15. US 11130740

    Substituted 2,3-dihydro-1H-indene analogs and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  16. US 11130726

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  17. US 11129909

    Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof

    UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  18. US 11130746

    Therapeutic compounds

    C4X Discovery Limited · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  19. US 11129864

    Method for obtaining a plant extract and associated compositions

    ETHNODYNE · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  20. US 11129895

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  21. US 11129869

    Pharmaceutical compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  22. US 11129876

    Etanercept formulations stabilized with amino acids

    Coherus BioSciences, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  23. US 11129863

    Composition, preparation method thereof, and application thereof in the prevention and treatment of mammary gland disease

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  24. US 11129856

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.